通过三方策略的高稳定性和低刺激性恩罗夫洛克萨-胆固醇素组合注射
Liyan Jia1, Kaixiang Zhou1, Xuechun Zhang1
1National Key Laboratory of Veterinary Public Health and Safety, College of Veterinary Medicine, China Agricultural University, Beijing, 100193, People's Republic of China.
Drug design, development and therapy
|September 15, 2025
概括
一个新的三方策略显著提高了恩罗夫洛克萨的溶解性,使得稳定的恩罗夫洛克萨-胆固醇素组合注射成为可能. 这种方法提高了抗菌疗效,减少了治疗细菌感染的毒性.
科学领域:
- 制药化学 制药化学 制药化学
- 兽医医学 兽医医学 兽医医学
- 药物运输 药物运输 药物运输
背景情况:
- 细菌耐药性和有限的新抗微生物药物开发需要组合疗法.
- 配方方面的挑战,特别是药物的溶解性和稳定性,阻碍了有效的组合药物开发.
- 恩罗夫洛克萨的低溶解度阻碍了其与其他药物的共同配方.
研究的目的:
- 使用一种新的三方策略,开发一种稳定的恩罗夫洛克萨-胆固醇素注射组合.
- 调查配方过程背后的分子机制.
- 评估组合注射的体外和体外安全性和有效性.
主要方法:
- 采用了三方策略,包括恩罗夫洛克萨盐的形成,1,2-二醇的添加和pH的调整.
- 基于希什菲尔德表面 (IGMH),NMR和UV视光谱的独立梯度模型被用于机械研究.
- 在体外和体外的评估评估评估了刺激性,毒性和治疗效果,对*Pasteurella multocida*.
主要成果:
- 三方策略使恩罗夫洛克萨的溶解度增加了1500倍,确保了6个月的稳定性.
- 1,2-二醇改善了结,并抑制了恩罗夫洛克萨的自我聚合.
- 组合注射没有显著的肝/毒性,并在*P. multocida*肺炎模型中实现了62.5%的生存率.
结论:
- 三方策略有效地克服了复杂配方中的恩罗夫洛克萨沉和pH限制.
- 这种方法提高了恩罗夫洛克萨-胆固醇素组合的可溶性,稳定性和治疗效果.
- 这些发现为开发复杂的抗菌配方提供了新的解决方案,特别是用于兽医应用.
相关概念视频
01:27Combined Effects of Drugs: Synergism
6.8K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
6.8K
01:22Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
179
Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
179
01:05Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
200
Body:Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
200
01:28Antimicrobial Effectiveness
908
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
908
00:57Antibiotic Selection
59.4K
Overview
59.4K
01:21Drug Accumulation During Multiple Dosing: Repetitive IV Injections
256
Calculating drug dosage and accumulation in multiple-dose regimens is crucial for achieving therapeutic efficacy while avoiding toxicity. This involves determining the plasma drug concentrations over time to optimize dosing schedules. The principle of superposition is fundamental in this process, allowing for the prediction of drug concentration in plasma following multiple doses based on single-dose data.The principle of superposition asserts that the plasma concentration-time curves from...
256